Atreca Inc BCEL

Alternate Symbol(s): COLUF

Atreca, Inc. is a clinical-stage biopharmaceutical company. The Company is discovering and developing antibody-based therapeutics to treat a range of solid tumor types. Its most advanced product candidate, ATRC-101, is a monoclonal antibody with a mechanism of action and target derived from an antibody identified using its discovery platform. ATRC-101 reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal and breast cancer samples from multiple patients. It commenced clinical development of ATRC-101 with a Phase Ib clinical trial evaluating ATRC-101 as a monotherapy in patients with select solid tumors and opens a new cohort to evaluate ATRC-101 in combination with pembrolizumab, a PD-1 checkpoint inhibitor. It is also advancing additional product candidates using its discovery platform. Its oncology programs include APN-497444, an ADC against a tumor glycan target, and APN-346958, a CD3 bispecific T-cell engager against an RNA-binding protein target.

PINL:BCEL - Post by User

Atreca Inc

Bullboard Posts

Post by Hammerbit_4on Jan 17, 2014 9:21pm

264 Views

Post# 22106698

whatever I did my DD years ago clown

beware

posted on Feb 16, 09 10:30AM

cant be a very good sign when chairmen of your joint venture partners are getting murdered google Josimar Elizio Barbosa PRESIDENT of COOMIGASP which is actally cooperative mining of miners of serra pelada was gunned down in may 2008/also murdered a few years back was Antonio Clenio Cunha Lemos the committee is chaired by high ranking officals of the military police also the membership of coomigasp figures they are owned 260 millions dont forget also the claim is only 100 hectares

Bullboard Posts

Building on success: Silvercorp’s acquisition of Adventus